Profile data is unavailable for this security.
About the company
Kyowa Kirin Co., Ltd., formerly Kyowa Hakko Kirin Co., Ltd. is a Japan-based company principally engaged in the manufacture and sale of medical drugs. The Company operates through two business segments. Pharmaceuticals segment conducts research, development, manufacture and sale of pharmaceuticals and other products. Bio-chemicals segment is involved in the research, development, manufacture and sale of pharmaceuticals and industrial raw materials mainly for amino acid and nucleic acid related substances, as well as healthcare products.
- Revenue in JPY (TTM)325.83bn
- Net income in JPY38.80bn
- Incorporated1949
- Employees7.24k
- LocationKyowa Kirin Co LtdOtemachi Financial City Grand Cube1-9-2, Ote-machiCHIYODA-KU 100-0004JapanJPN
- Phone+81 352057200
- Fax+81 352057182
- Websitehttps://www.kyowakirin.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alfresa Holdings Corporation | 2.65tn | 41.24bn | 560.05bn | 12.08k | 12.24 | 1.16 | 10.68 | 0.211 | 194.70 | 194.70 | 12,525.64 | 2,056.68 | 1.96 | 17.63 | 4.19 | 219,751,500.00 | 3.05 | 2.64 | 8.69 | 7.76 | 7.59 | 7.35 | 1.56 | 1.30 | 1.04 | -- | 0.0034 | 24.24 | 1.44 | 1.06 | 17.17 | 10.28 | -8.14 | 10.07 |
| Medipal Holdings Corp | 3.19tn | 34.12bn | 580.26bn | 13.87k | 16.43 | 1.07 | 10.03 | 0.1819 | 144.44 | 144.44 | 13,544.75 | 2,222.07 | 1.94 | 19.85 | 4.46 | 229,998,000.00 | 2.66 | 2.52 | 7.49 | 7.58 | 7.30 | 7.18 | 1.37 | 1.25 | 1.05 | -- | 0.0867 | 22.86 | 1.13 | 1.54 | -1.21 | 6.16 | -5.66 | 10.56 |
| Peptidream Inc | 7.22bn | 2.77bn | 617.15bn | 104.00 | 225.83 | 35.33 | 187.49 | 85.52 | 21.81 | 21.81 | 55.58 | 139.41 | 0.395 | 7.28 | 2.38 | 69,390,600.00 | 15.16 | 15.25 | 17.11 | 17.12 | 77.12 | 73.97 | 38.39 | 37.81 | 4.13 | -- | 0.00 | 0.00 | 12.29 | 54.53 | 18.62 | 79.53 | 21.67 | -- |
| Nippon Shinyaku Co., Ltd. | 116.31bn | 17.29bn | 651.23bn | 1.95k | 36.11 | 4.59 | 31.48 | 5.60 | 256.69 | 256.69 | 1,726.83 | 2,019.97 | 0.7142 | 2.63 | 2.59 | 59,615,070.00 | 10.63 | 7.45 | 12.44 | 8.79 | 56.12 | 52.42 | 14.88 | 11.12 | 3.68 | -- | 0.00 | 28.21 | 13.08 | 8.44 | 25.86 | 23.17 | 2.91 | 24.93 |
| Sumitomo Dainippon Pharma Co Ltd | 460.84bn | 40.08bn | 708.66bn | 6.14k | 17.65 | 1.45 | 12.93 | 1.54 | 100.89 | 100.89 | 1,159.94 | 1,231.91 | 0.566 | 1.74 | 3.82 | 75,055,380.00 | 4.92 | 4.62 | 6.50 | 6.17 | 75.35 | 75.05 | 8.70 | 8.23 | 1.56 | 71.50 | 0.0581 | 25.64 | -1.62 | 3.45 | -9.02 | 19.37 | -9.74 | 9.24 |
| Santen Pharmaceutical Co Ltd | 236.68bn | 31.50bn | 732.91bn | 4.07k | 23.61 | 2.54 | 16.72 | 3.10 | 77.64 | 77.64 | 583.79 | 722.17 | 0.619 | 2.80 | 2.91 | 58,109,260.00 | 8.23 | 9.66 | 9.54 | 11.69 | 61.19 | 62.44 | 13.30 | 16.38 | 2.93 | 26.66 | 0.1319 | 30.74 | 4.04 | 9.86 | -9.34 | 10.14 | 7.23 | 5.39 |
| ONO PHARMACEUTICAL CO., LTD. | 291.38bn | 52.63bn | 1.03tn | 3.56k | 18.55 | 1.76 | 16.07 | 3.54 | 102.44 | 102.44 | 567.04 | 1,079.17 | 0.4626 | 2.67 | 3.56 | 81,962,020.00 | 8.38 | 6.87 | 9.51 | 7.73 | 71.03 | 73.30 | 18.12 | 18.01 | 2.03 | -- | 0.0149 | 54.02 | 10.23 | 15.04 | 2.50 | 20.43 | 18.15 | 4.56 |
| Kyowa Kirin Co Ltd | 325.83bn | 38.80bn | 1.06tn | 7.24k | 27.52 | 1.59 | 17.51 | 3.25 | 71.30 | 126.05 | 598.93 | 1,235.61 | 0.4394 | 1.65 | 3.39 | 44,991,300.00 | 5.23 | 4.87 | 5.81 | 5.52 | 69.99 | 62.87 | 11.91 | 9.94 | 5.42 | 32.00 | 0.026 | 43.23 | -1.94 | 0.3452 | 26.84 | 12.59 | -10.32 | 6.96 |
Data as of Oct 11 2019. Currency figures normalised to Kyowa Kirin Co Ltd's reporting currency: Japanese Yen JPY
11.23%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 30 Aug 2019 | 17.80m | 3.30% |
| Nikko Asset Management Co., Ltd.as of 11 Jul 2019 | 7.82m | 1.45% |
| Daiwa Asset Management Co. Ltd.as of 30 Sep 2019 | 7.40m | 1.37% |
| The Vanguard Group, Inc.as of 31 Aug 2019 | 6.69m | 1.24% |
| Norges Bank Investment Managementas of 31 Dec 2018 | 4.32m | 0.80% |
| Wellington Management Co. LLPas of 31 Aug 2019 | 4.11m | 0.76% |
| BlackRock Fund Advisorsas of 03 Oct 2019 | 3.91m | 0.72% |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd.as of 30 Sep 2019 | 3.79m | 0.70% |
| Massachusetts Financial Services Co.as of 31 Aug 2019 | 2.96m | 0.55% |
| Invesco Advisers, Inc.as of 31 May 2019 | 1.82m | 0.34% |
More ▼
Data from 31 Dec 2018 - 30 Jun 2019Source: FactSet Research Systems Inc.
